I can see the status bar

Chapter 1178
Data, especially personal data, is actually more valuable than many people think.

A person's personal data may not be much - it can only outline a person's various situations and profiles.But even such "nothing" data, there are still countless Internet companies salivating.

After all, if an accurate personal profile can be obtained, then the company can accurately classify the person's personal situation, and carry out more accurate advertising delivery, so as to obtain the maximum benefit with the minimum advertising cost.

For Internet companies, such data still has such a huge advantage.For pharmaceutical companies, case data will only become more precious.

A large amount of reliable case data can point out the direction for the research and development of enterprises.This is the lifeline of pharmaceutical companies.The data that pharmaceutical companies usually use as a reference is mainly divided into three types-scientific research data, public health data, and data obtained from their own research.

Among the three types of data, scientific research data may have the greatest deviation, but it also has the greatest reference significance.After all, the essence of scientific research is to discover problems and find solutions.Whenever researchers discover and report a new type of disease or discover a new treatment method, apart from the research author himself and the members of the research team, these large pharmaceutical companies are probably the happiest.

The discovery of a new disease often means a new market area.The discovery of a new treatment means that a brand new runway may suddenly appear in the market that has already killed each other.

And public health data are often the most accurate.Such data comes from the public health departments of various countries, and each data collection and summary statistics consume a lot of manpower and material resources.However, due to the government's own interests and limited resources, these data will not include everything like scientific research data.In fact, the most common diseases in this batch of data are those with a large number of patients.

Such as hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, renal insufficiency and other chronic diseases.These diseases, which have a relatively high incidence rate and will have a major impact or drag on the entire public health system, are the key directions of public health statistics.

Of course, infectious diseases are also an important part of public health statistics.

Whether it is these chronic diseases with a high incidence rate or infectious diseases...they are all bloody Red Sea battlefields that have been killed by various pharmaceutical companies.In such a field, public health data can help pharmaceutical companies have a very clear understanding of this market, but the help is limited to this.

For pharmaceutical companies, the third type of survey data is what they need most.Through the on-site statistics of the staff they send, or simply using the case data of the medical institutions they cooperate with, they can often discover some noteworthy trends and changes in advance before the scientific research data and public health data are released.

For example, the incidence of a certain disease is gradually increasing.For example, patients receiving a certain drug treatment have a significant increase or decrease in the morbidity and mortality of other diseases.

In other words, such data is a huge treasure mountain for pharmaceutical companies.Although it is not sure what good things can be excavated from it, the content inside is definitely helpful to them.

No wonder... Takeda suddenly wants to buy a game.

While Liu Baoguo suddenly realized, he also fell into a brand new "sorrow".The reason for his "sorrow" is simple-data is a very valuable thing, and it may be of great help to Takeda Pharmaceutical.

But they give too little.

According to Takeda Pharmaceutical's asking price, Liu Baoguo and the others can at most recover the research and development costs of the entire system, and then make a small profit.But... no company spends a lot of money and goes through a lot of experience to develop products, just to recover the cost and make a small profit.

What's more, the relationship here is really too big.No matter how courageous Liu Baoguo himself is, he would not dare to hand over the data and information of the cooperation with the top three hospitals to foreign companies.

Sensitive personal data is exported abroad, which will be investigated for criminal responsibility.

Thinking of this, Liu Baoguo couldn't help but breathe a sigh of relief.Fortunately, Takeda's asking price was very low. If I was tempted by the high asking price before, I would feel uncomfortable now.

·
·
·
Liu Baoguo figured it out, thanked Sun Lien repeatedly before hanging up the phone.This matter has too much to do with it, and Takeda's offer is far from enough to make him lose his mind and take risks.

Everyone has an extra weight in their hearts, and Liu Baoguo is no exception.It's just that in his heart, the company he founded is far more important than the price offered by Takeda.

Sun Lien, who hung up the phone, thought for a while and decided to report this matter to Song Wen.

Although it has long been no secret that Takeda Pharmaceuticals is greedy for data, the fact that they want to purchase a piece of software to obtain medical records... is a bit outrageous.

The data given by the Comprehensive Diagnostic Center are already quite a lot. Although they are all desensitized data cases, for Takeda and their rare disease department, these data are truly invaluable.

And these data are approved by relevant departments and can be handed over to Takeda.More importantly, the comprehensive diagnostic center has just started, and as time goes by, the data collected here will only become more and more important.

Leaving good security data alone, but also contacting other companies trying to obtain data through improper channels... This matter is weird from beginning to end.

Sun Li'en thinks he is not a person who is good at trying to figure out people's hearts.Especially in this incident, he didn't even know whose mind he should try to figure out--that Xu Yourong's alumni junior sister who became a high-ranking district, the old fox Xiao Linfeng...or the unlucky Xiaolin Xun who couldn't be more unlucky.

If you don't know it yourself, you should ask someone who can figure it out.Sun Li'en called Song Wen and told the story.

"Understood." Song Wen on the other end of the phone didn't respond any more, but resolutely hung up the phone after confirming with Sun Lien twice.

Although Song Wen's actions made Sun Li'en a little confused, but this kind of confusion is not necessarily bad.Anyway, Sun Lien didn't plan to think about the twists and turns inside, and just waited for Song Wen to notify the result later.

His current brain cells have more important work to do than this.

"The monkeys have all received it, and we are starting the first phase of the experiment." This is the message sent by the knowledgeable Shen Xi to Sun Lien, "We are going to cooperate with the Institute of Respiratory Research to study the damage mechanism of the new coronavirus on the alveoli ...We need to verify again whether the previously discovered alveolar regeneration can be reproduced."

　Luo was dizzy when he coded on a train with the prefix K on the train...

　　If I had known it earlier, I would have written it on the bullet train.

　　I will arrive in Haikou at [-]:[-] tomorrow morning, and I will have time to continue working after a short rest.

　　
　
(End of this chapter)